Oaktree Acquisition Corp. III Life Sciences (OACCW)
Oaktree Acquisition Corp. III Life Sciences operates in the Shell Companies industry of the Financial Services sector, headquartered in Los Angeles, CA, US. The stock last traded at $1.03, up 0.98% on the session, giving a market capitalisation of $289.3M. On trailing twelve-month figures it carries a trailing P/E of 37.23, a net margin of 0.0%. Its beta of 0.20 implies it has historically moved less than the broad market.
Oaktree Acquisition Corp. III Life Sciences presently lacks significant commercial operations. Its primary focus is on completing a business combination, which could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization, or a similar corporate transaction, with one or more entities. The company aims to identify and acquire businesses operating in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors across North America and Europe. Incorporated in 2024, its base of operations is in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences is most often compared with the following Financial Services names: